
Neuralink Expands Brain Implant Trials with 12 Global Patients
Sep 10, 2025 01:57 am UTC| Technology Business Science Health
Elon Musks brain-computer interface company, Neuralink, announced that 12 people worldwide have now received its brain implants. This is up from seven patients reported in June, when the companys partner, Barrow...

Novartis to Acquire Tourmaline Bio in $1.4 Billion Deal to Boost Heart Disease Portfolio
Sep 09, 2025 06:23 am UTC| Business Health
Novartis announced it will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at approximately $1.4 billion on a fully diluted basis. The Swiss pharmaceutical giant confirmed...

FDA Fast-Tracks Nicotine Pouch Reviews for Major Tobacco Firms
Sep 08, 2025 04:43 am UTC| Business Governance Health
The U.S. Food and Drug Administration (FDA) is set to fast-track reviews of nicotine pouches from Philip Morris International (PMI), Altria, Reynolds American (part of British American Tobacco), and Turning Point Brands in...

Sun Pharma and Lupin Advance Affordable Anti-Obesity Pills in India
Sep 08, 2025 02:39 am UTC| Business Health
Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing affordable anti-obesity drugs as the country faces a growing health crisis. According to Mint, both...

White House Holds Off on IVF Insurance Mandate Despite Trump’s Access Pledge
Aug 03, 2025 12:03 pm UTC| Politics Governance Health
The White House has no immediate plans to require insurance companies to cover in vitro fertilization (IVF), despite U.S. President Donald Trumps campaign pledge to expand access to fertility treatments, according to The...

Robert F. Kennedy Jr. Vows Overhaul of U.S. Vaccine Injury Compensation Program
Jul 29, 2025 02:00 am UTC| Governance Health Politics
U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a...

FDA Approves PTC Therapeutics’ Sephience for Rare Genetic Disorder PKU
Jul 29, 2025 00:54 am UTC| Governance Health
The U.S. Food and Drug Administration (FDA) has approved PTC Therapeutics (NASDAQ:PTCT) oral drug Sephience to treat phenylketonuria (PKU), a rare inherited metabolic disorder affecting the bodys ability to break down the...